Elderly coagulation risk in a globalized world: burden, biomarkers, and management in Africa - a narrative review

Emmanuel Ifeanyi Obeagu1

  • 1Department of Biomedical and Laboratory Science, Africa University, Mutare, Zimbabwe.

Insights

Aging populations face increased coagulation disorders, especially in Africa. Limited diagnostics and resources challenge the recognition and management of these critical conditions in the elderly.

Area of Science:

  • Gerontology
  • Hematology
  • Public Health in Africa

Background:

  • Global life expectancy increases, highlighting age-related health issues.
  • Coagulation disorders are a major cause of illness and death in older adults.
  • Africa faces a growing burden of coagulation abnormalities due to demographic and disease trends.

Purpose of the Study:

  • To highlight the challenges in diagnosing and managing coagulation disorders in elderly Africans.
  • To assess the role and availability of key coagulation biomarkers in African healthcare settings.
  • To explore the potential of emerging biomarkers for improved patient assessment.

Main Methods:

  • Review of current literature on coagulation disorders in the elderly.
  • Analysis of the impact of demographic shifts and disease prevalence in Africa.
  • Evaluation of the utility and accessibility of standard coagulation tests (e.g., D-dimer, PT, aPTT, platelet indices).

Main Results:

  • Coagulation disorders present a significant, under-recognized challenge in aging African populations.
  • Standard diagnostic tools for coagulation disorders are inconsistently available and utilized in Africa.
  • Limited resources and data impede effective risk stratification and timely intervention.

Conclusions:

  • There is a critical need to improve the recognition and management of coagulation disorders in elderly Africans.
  • Enhanced accessibility and utilization of diagnostic biomarkers are essential.
  • Further research into emerging biomarkers may offer improved diagnostic capabilities.

Related Concept Videos

Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
191
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
273
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.1K
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
182